Business · 23/08/2011Updated: 10/17/2026 · 1 min read

FDA's Vaccines and Related Biological Products Advisory Committee to Review Amendment of Notice Regarding COVID-19 Vaccines

The US FDA's Vaccines and Related Biological Products Advisory Committee will review an amendment to a notice regarding COVID-19 vaccines, as part of its ongoing efforts to ensure the safety and efficacy of these vaccines.